nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—Paget's disease of bone—osteoporosis	0.131	1	CtDrD
Alendronate—FDPS—osteoporosis	0.103	1	CbGaD
Alendronate—Diphosphonates—Ibandronate—osteoporosis	0.0742	0.305	CiPCiCtD
Alendronate—Diphosphonates—Pamidronate—osteoporosis	0.0562	0.231	CiPCiCtD
Alendronate—Diphosphonates—Etidronic acid—osteoporosis	0.0562	0.231	CiPCiCtD
Alendronate—Diphosphonates—Risedronate—osteoporosis	0.0562	0.231	CiPCiCtD
Alendronate—Ibandronate—osteoporosis	0.0528	0.265	CrCtD
Alendronate—PTPRS—Etidronic acid—osteoporosis	0.0403	0.272	CbGbCtD
Alendronate—Etidronic acid—osteoporosis	0.0372	0.187	CrCtD
Alendronate—Risedronate—osteoporosis	0.0372	0.187	CrCtD
Alendronate—Zoledronate—osteoporosis	0.0372	0.187	CrCtD
Alendronate—Pamidronate—osteoporosis	0.035	0.175	CrCtD
Alendronate—ATP6V1A—Etidronic acid—osteoporosis	0.0291	0.197	CbGbCtD
Alendronate—FDPS—Ibandronate—osteoporosis	0.0291	0.197	CbGbCtD
Alendronate—FDPS—Pamidronate—osteoporosis	0.0221	0.149	CbGbCtD
Alendronate—FDPS—Risedronate—osteoporosis	0.0167	0.113	CbGbCtD
Alendronate—FDPS—Zoledronate—osteoporosis	0.0108	0.0728	CbGbCtD
Alendronate—Histamine Phosphate—Risedronate—osteoporosis	0.00811	0.0601	CrCrCtD
Alendronate—Histamine Phosphate—Pamidronate—osteoporosis	0.00762	0.0565	CrCrCtD
Alendronate—Risedronate—Ibandronate—osteoporosis	0.00661	0.049	CrCrCtD
Alendronate—Etidronic acid—Ibandronate—osteoporosis	0.00661	0.049	CrCrCtD
Alendronate—Zoledronate—Ibandronate—osteoporosis	0.00661	0.049	CrCrCtD
Alendronate—Clodronate—Etidronic acid—osteoporosis	0.00644	0.0477	CrCrCtD
Alendronate—Clodronate—Zoledronate—osteoporosis	0.00644	0.0477	CrCrCtD
Alendronate—Clodronate—Pamidronate—osteoporosis	0.00606	0.0449	CrCrCtD
Alendronate—Pamidronate—Ibandronate—osteoporosis	0.00584	0.0433	CrCrCtD
Alendronate—Ibandronate—Zoledronate—osteoporosis	0.00539	0.0399	CrCrCtD
Alendronate—Ibandronate—Risedronate—osteoporosis	0.00539	0.0399	CrCrCtD
Alendronate—Ibandronate—Etidronic acid—osteoporosis	0.00539	0.0399	CrCrCtD
Alendronate—Ibandronate—Pamidronate—osteoporosis	0.00507	0.0375	CrCrCtD
Alendronate—Risedronate—Zoledronate—osteoporosis	0.00466	0.0345	CrCrCtD
Alendronate—Etidronic acid—Zoledronate—osteoporosis	0.00466	0.0345	CrCrCtD
Alendronate—Zoledronate—Etidronic acid—osteoporosis	0.00466	0.0345	CrCrCtD
Alendronate—Zoledronate—Risedronate—osteoporosis	0.00466	0.0345	CrCrCtD
Alendronate—Risedronate—Etidronic acid—osteoporosis	0.00466	0.0345	CrCrCtD
Alendronate—Etidronic acid—Risedronate—osteoporosis	0.00466	0.0345	CrCrCtD
Alendronate—Risedronate—Pamidronate—osteoporosis	0.00438	0.0324	CrCrCtD
Alendronate—Etidronic acid—Pamidronate—osteoporosis	0.00438	0.0324	CrCrCtD
Alendronate—Zoledronate—Pamidronate—osteoporosis	0.00438	0.0324	CrCrCtD
Alendronate—Pamidronate—Zoledronate—osteoporosis	0.00412	0.0305	CrCrCtD
Alendronate—Pamidronate—Risedronate—osteoporosis	0.00412	0.0305	CrCrCtD
Alendronate—Pamidronate—Etidronic acid—osteoporosis	0.00412	0.0305	CrCrCtD
Alendronate—FDPS—jaw skeleton—osteoporosis	0.00167	0.316	CbGeAlD
Alendronate—FDPS—periosteum—osteoporosis	0.00126	0.239	CbGeAlD
Alendronate—PTPRS—ECM proteoglycans—IBSP—osteoporosis	0.000908	0.157	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—TNFSF11—osteoporosis	0.000893	0.154	CbGpPWpGaD
Alendronate—PTPN4—uterus—osteoporosis	0.000464	0.0877	CbGeAlD
Alendronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—LTF—osteoporosis	0.00042	0.0724	CbGpPWpGaD
Alendronate—PTPRE—bone marrow—osteoporosis	0.000414	0.0783	CbGeAlD
Alendronate—PTPN4—bone marrow—osteoporosis	0.000393	0.0744	CbGeAlD
Alendronate—Ibandronate—FDPS—osteoporosis	0.00034	0.317	CrCbGaD
Alendronate—PTPRS—bone marrow—osteoporosis	0.000337	0.0638	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—IL6R—osteoporosis	0.000317	0.0547	CbGpPWpGaD
Alendronate—Pamidronate—FDPS—osteoporosis	0.000297	0.277	CrCbGaD
Alendronate—PTPRS—Extracellular matrix organization—IBSP—osteoporosis	0.000259	0.0447	CbGpPWpGaD
Alendronate—Risedronate—FDPS—osteoporosis	0.00024	0.223	CrCbGaD
Alendronate—ATP6V1A—uterus—osteoporosis	0.000229	0.0434	CbGeAlD
Alendronate—ATP6V1A—bone marrow—osteoporosis	0.000194	0.0368	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—MYC—osteoporosis	0.000188	0.0324	CbGpPWpGaD
Alendronate—FDPS—uterus—osteoporosis	0.000173	0.0327	CbGeAlD
Alendronate—Zoledronate—FDPS—osteoporosis	0.000154	0.144	CrCbGaD
Alendronate—FDPS—bone marrow—osteoporosis	0.000146	0.0277	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—IL6—osteoporosis	0.000141	0.0244	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—P4HB—osteoporosis	0.000126	0.0218	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—COL1A2—osteoporosis	0.000124	0.0214	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—CTSK—osteoporosis	0.00012	0.0207	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—FGA—osteoporosis	0.00011	0.0189	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—BMP2—osteoporosis	0.000102	0.0176	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—FGB—osteoporosis	9.98e-05	0.0172	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—COL1A1—osteoporosis	9.54e-05	0.0164	CbGpPWpGaD
Alendronate—PTPRS—ECM proteoglycans—TGFB1—osteoporosis	9.5e-05	0.0164	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—KL—osteoporosis	7.69e-05	0.0132	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—SPP1—osteoporosis	6.18e-05	0.0106	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IRS2—osteoporosis	5.27e-05	0.00908	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.19e-05	0.00894	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IRS1—osteoporosis	4.6e-05	0.00793	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6R—osteoporosis	4.32e-05	0.00745	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.28e-05	0.00737	CbGpPWpGaD
Alendronate—Zoledronate—CA2—osteoporosis	4.26e-05	0.0397	CrCbGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.03e-05	0.00695	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.93e-05	0.00678	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PKM—osteoporosis	3.64e-05	0.00627	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SOST—osteoporosis	3.64e-05	0.00627	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PGLS—osteoporosis	3.45e-05	0.00595	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ANTXR2—osteoporosis	3.45e-05	0.00595	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.14e-05	0.00542	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—GSN—osteoporosis	2.93e-05	0.00506	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—TGFB1—osteoporosis	2.71e-05	0.00467	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.67e-05	0.00461	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—LRP5—osteoporosis	2.55e-05	0.0044	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SOST—osteoporosis	2.55e-05	0.00439	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—LRP6—osteoporosis	2.44e-05	0.00421	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PKM—osteoporosis	2.44e-05	0.0042	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—LTF—osteoporosis	2.34e-05	0.00404	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RPL24—osteoporosis	2.34e-05	0.00404	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GPD2—osteoporosis	2.31e-05	0.00398	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PGLS—osteoporosis	2.31e-05	0.00398	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTH1R—osteoporosis	2.3e-05	0.00397	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CALCR—osteoporosis	2.3e-05	0.00397	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PNP—osteoporosis	2.11e-05	0.00364	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ATIC—osteoporosis	2.11e-05	0.00364	CbGpPWpGaD
Alendronate—Nausea—Ergocalciferol—osteoporosis	2.09e-05	0.000735	CcSEcCtD
Alendronate—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	2.09e-05	0.000733	CcSEcCtD
Alendronate—Erythema—Pamidronate—osteoporosis	2.09e-05	0.000732	CcSEcCtD
Alendronate—Urticaria—Etidronic acid—osteoporosis	2.08e-05	0.00073	CcSEcCtD
Alendronate—Oedema peripheral—Conjugated Estrogens—osteoporosis	2.08e-05	0.000729	CcSEcCtD
Alendronate—Abdominal pain—Etidronic acid—osteoporosis	2.07e-05	0.000727	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Estropipate—osteoporosis	2.07e-05	0.000724	CcSEcCtD
Alendronate—Angioedema—Ethinyl Estradiol—osteoporosis	2.06e-05	0.000722	CcSEcCtD
Alendronate—Dysgeusia—Pamidronate—osteoporosis	2.04e-05	0.000717	CcSEcCtD
Alendronate—ATP6V1A—Disease—ACP5—osteoporosis	2.03e-05	0.00351	CbGpPWpGaD
Alendronate—Malaise—Ethinyl Estradiol—osteoporosis	2.03e-05	0.000712	CcSEcCtD
Alendronate—Anaemia—Risedronate—osteoporosis	2.03e-05	0.000712	CcSEcCtD
Alendronate—Abdominal discomfort—Estradiol—osteoporosis	2.02e-05	0.000709	CcSEcCtD
Alendronate—Muscle spasms—Pamidronate—osteoporosis	2.01e-05	0.000704	CcSEcCtD
Alendronate—Angioedema—Risedronate—osteoporosis	2.01e-05	0.000704	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Raloxifene—osteoporosis	2e-05	0.000702	CcSEcCtD
Alendronate—Dyspepsia—Estropipate—osteoporosis	2e-05	0.0007	CcSEcCtD
Alendronate—Erythema multiforme—Conjugated Estrogens—osteoporosis	1.99e-05	0.000699	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Ibandronate—osteoporosis	1.98e-05	0.000695	CcSEcCtD
Alendronate—Vertigo—Risedronate—osteoporosis	1.97e-05	0.000692	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Calcitriol—osteoporosis	1.94e-05	0.00068	CcSEcCtD
Alendronate—Pain—Estropipate—osteoporosis	1.94e-05	0.00068	CcSEcCtD
Alendronate—Constipation—Estropipate—osteoporosis	1.94e-05	0.00068	CcSEcCtD
Alendronate—Ill-defined disorder—Pamidronate—osteoporosis	1.94e-05	0.000679	CcSEcCtD
Alendronate—Alopecia—Zoledronate—osteoporosis	1.94e-05	0.000679	CcSEcCtD
Alendronate—Dyspepsia—Raloxifene—osteoporosis	1.93e-05	0.000678	CcSEcCtD
Alendronate—Hypersensitivity—Etidronic acid—osteoporosis	1.93e-05	0.000677	CcSEcCtD
Alendronate—Anaemia—Pamidronate—osteoporosis	1.93e-05	0.000677	CcSEcCtD
Alendronate—Photosensitivity reaction—Estradiol—osteoporosis	1.92e-05	0.000675	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6—osteoporosis	1.92e-05	0.00332	CbGpPWpGaD
Alendronate—Dyspepsia—Ibandronate—osteoporosis	1.91e-05	0.000671	CcSEcCtD
Alendronate—Angioedema—Pamidronate—osteoporosis	1.91e-05	0.000669	CcSEcCtD
Alendronate—Erythema—Zoledronate—osteoporosis	1.91e-05	0.000669	CcSEcCtD
Alendronate—Discomfort—Ethinyl Estradiol—osteoporosis	1.89e-05	0.000664	CcSEcCtD
Alendronate—ATP6V1A—Disease—TPI1—osteoporosis	1.89e-05	0.00326	CbGpPWpGaD
Alendronate—Malaise—Pamidronate—osteoporosis	1.88e-05	0.00066	CcSEcCtD
Alendronate—Pain—Raloxifene—osteoporosis	1.88e-05	0.000659	CcSEcCtD
Alendronate—Chest pain—Risedronate—osteoporosis	1.87e-05	0.000656	CcSEcCtD
Alendronate—Myalgia—Risedronate—osteoporosis	1.87e-05	0.000656	CcSEcCtD
Alendronate—Dysgeusia—Zoledronate—osteoporosis	1.87e-05	0.000655	CcSEcCtD
Alendronate—Alopecia—Conjugated Estrogens—osteoporosis	1.86e-05	0.000654	CcSEcCtD
Alendronate—Constipation—Ibandronate—osteoporosis	1.86e-05	0.000652	CcSEcCtD
Alendronate—Pain—Ibandronate—osteoporosis	1.86e-05	0.000652	CcSEcCtD
Alendronate—Pruritus—Etidronic acid—osteoporosis	1.85e-05	0.00065	CcSEcCtD
Alendronate—Gastrointestinal pain—Estropipate—osteoporosis	1.85e-05	0.00065	CcSEcCtD
Alendronate—Erythema—Conjugated Estrogens—osteoporosis	1.84e-05	0.000644	CcSEcCtD
Alendronate—Muscle spasms—Zoledronate—osteoporosis	1.83e-05	0.000643	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—MGLL—osteoporosis	1.83e-05	0.00316	CbGpPWpGaD
Alendronate—Infection—Ethinyl Estradiol—osteoporosis	1.83e-05	0.00064	CcSEcCtD
Alendronate—Pain—Calcitriol—osteoporosis	1.82e-05	0.000638	CcSEcCtD
Alendronate—Constipation—Calcitriol—osteoporosis	1.82e-05	0.000638	CcSEcCtD
Alendronate—Flatulence—Conjugated Estrogens—osteoporosis	1.81e-05	0.000634	CcSEcCtD
Alendronate—Urticaria—Estropipate—osteoporosis	1.8e-05	0.000632	CcSEcCtD
Alendronate—Dysgeusia—Conjugated Estrogens—osteoporosis	1.8e-05	0.00063	CcSEcCtD
Alendronate—FDPS—Metabolism—OXCT1—osteoporosis	1.8e-05	0.0031	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CA2—osteoporosis	1.8e-05	0.0031	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Raloxifene—osteoporosis	1.8e-05	0.00063	CcSEcCtD
Alendronate—Diarrhoea—Etidronic acid—osteoporosis	1.79e-05	0.000629	CcSEcCtD
Alendronate—Body temperature increased—Estropipate—osteoporosis	1.79e-05	0.000629	CcSEcCtD
Alendronate—Abdominal pain—Estropipate—osteoporosis	1.79e-05	0.000629	CcSEcCtD
Alendronate—Feeling abnormal—Ibandronate—osteoporosis	1.79e-05	0.000628	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—LRP5—osteoporosis	1.79e-05	0.00308	CbGpPWpGaD
Alendronate—Infection—Risedronate—osteoporosis	1.78e-05	0.000624	CcSEcCtD
Alendronate—Gastrointestinal pain—Ibandronate—osteoporosis	1.78e-05	0.000624	CcSEcCtD
Alendronate—ATP6V1A—Disease—P4HB—osteoporosis	1.78e-05	0.00306	CbGpPWpGaD
Alendronate—Myalgia—Pamidronate—osteoporosis	1.78e-05	0.000623	CcSEcCtD
Alendronate—Ill-defined disorder—Zoledronate—osteoporosis	1.77e-05	0.00062	CcSEcCtD
Alendronate—Muscle spasms—Conjugated Estrogens—osteoporosis	1.76e-05	0.000619	CcSEcCtD
Alendronate—Anaemia—Zoledronate—osteoporosis	1.76e-05	0.000618	CcSEcCtD
Alendronate—Discomfort—Pamidronate—osteoporosis	1.76e-05	0.000616	CcSEcCtD
Alendronate—FDPS—Metabolism—MGLL—osteoporosis	1.75e-05	0.00302	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—GAPDH—osteoporosis	1.74e-05	0.00301	CbGpPWpGaD
Alendronate—Angioedema—Zoledronate—osteoporosis	1.74e-05	0.000611	CcSEcCtD
Alendronate—Gastrointestinal pain—Calcitriol—osteoporosis	1.74e-05	0.00061	CcSEcCtD
Alendronate—Body temperature increased—Raloxifene—osteoporosis	1.74e-05	0.000609	CcSEcCtD
Alendronate—Abdominal pain—Raloxifene—osteoporosis	1.74e-05	0.000609	CcSEcCtD
Alendronate—Urticaria—Ibandronate—osteoporosis	1.73e-05	0.000606	CcSEcCtD
Alendronate—Malaise—Zoledronate—osteoporosis	1.72e-05	0.000603	CcSEcCtD
Alendronate—Body temperature increased—Ibandronate—osteoporosis	1.72e-05	0.000603	CcSEcCtD
Alendronate—Abdominal pain—Ibandronate—osteoporosis	1.72e-05	0.000603	CcSEcCtD
Alendronate—Vertigo—Zoledronate—osteoporosis	1.71e-05	0.000601	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—LRP6—osteoporosis	1.71e-05	0.00295	CbGpPWpGaD
Alendronate—Haemoglobin—Estradiol—osteoporosis	1.7e-05	0.000595	CcSEcCtD
Alendronate—Infection—Pamidronate—osteoporosis	1.69e-05	0.000593	CcSEcCtD
Alendronate—Urticaria—Calcitriol—osteoporosis	1.69e-05	0.000593	CcSEcCtD
Alendronate—Haemorrhage—Estradiol—osteoporosis	1.69e-05	0.000592	CcSEcCtD
Alendronate—Body temperature increased—Calcitriol—osteoporosis	1.68e-05	0.00059	CcSEcCtD
Alendronate—Abdominal pain—Calcitriol—osteoporosis	1.68e-05	0.00059	CcSEcCtD
Alendronate—Angioedema—Conjugated Estrogens—osteoporosis	1.68e-05	0.000588	CcSEcCtD
Alendronate—Hypersensitivity—Estropipate—osteoporosis	1.67e-05	0.000586	CcSEcCtD
Alendronate—Vomiting—Etidronic acid—osteoporosis	1.67e-05	0.000584	CcSEcCtD
Alendronate—Oedema peripheral—Estradiol—osteoporosis	1.66e-05	0.000583	CcSEcCtD
Alendronate—ATP6V1A—Disease—NFATC1—osteoporosis	1.66e-05	0.00286	CbGpPWpGaD
Alendronate—Rash—Etidronic acid—osteoporosis	1.65e-05	0.00058	CcSEcCtD
Alendronate—Dermatitis—Etidronic acid—osteoporosis	1.65e-05	0.000579	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.65e-05	0.00285	CbGpPWpGaD
Alendronate—Vertigo—Conjugated Estrogens—osteoporosis	1.65e-05	0.000578	CcSEcCtD
Alendronate—ATP6V1A—Disease—DKK1—osteoporosis	1.64e-05	0.00283	CbGpPWpGaD
Alendronate—Headache—Etidronic acid—osteoporosis	1.64e-05	0.000576	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Risedronate—osteoporosis	1.63e-05	0.000573	CcSEcCtD
Alendronate—Asthenia—Estropipate—osteoporosis	1.63e-05	0.000571	CcSEcCtD
Alendronate—Chest pain—Zoledronate—osteoporosis	1.62e-05	0.000569	CcSEcCtD
Alendronate—Myalgia—Zoledronate—osteoporosis	1.62e-05	0.000569	CcSEcCtD
Alendronate—Pruritus—Estropipate—osteoporosis	1.6e-05	0.000563	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.6e-05	0.00277	CbGpPWpGaD
Alendronate—Discomfort—Zoledronate—osteoporosis	1.6e-05	0.000562	CcSEcCtD
Alendronate—Hypersensitivity—Ibandronate—osteoporosis	1.6e-05	0.000562	CcSEcCtD
Alendronate—Erythema multiforme—Estradiol—osteoporosis	1.6e-05	0.00056	CcSEcCtD
Alendronate—ATP6V1A—Disease—WNT1—osteoporosis	1.58e-05	0.00273	CbGpPWpGaD
Alendronate—Dyspepsia—Risedronate—osteoporosis	1.58e-05	0.000553	CcSEcCtD
Alendronate—Constipation—Ethinyl Estradiol—osteoporosis	1.57e-05	0.000551	CcSEcCtD
Alendronate—Hypersensitivity—Calcitriol—osteoporosis	1.57e-05	0.00055	CcSEcCtD
Alendronate—Chest pain—Conjugated Estrogens—osteoporosis	1.56e-05	0.000548	CcSEcCtD
Alendronate—Myalgia—Conjugated Estrogens—osteoporosis	1.56e-05	0.000548	CcSEcCtD
Alendronate—Asthenia—Ibandronate—osteoporosis	1.56e-05	0.000547	CcSEcCtD
Alendronate—Nausea—Etidronic acid—osteoporosis	1.56e-05	0.000546	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Pamidronate—osteoporosis	1.55e-05	0.000544	CcSEcCtD
Alendronate—Diarrhoea—Estropipate—osteoporosis	1.55e-05	0.000544	CcSEcCtD
Alendronate—Infection—Zoledronate—osteoporosis	1.55e-05	0.000542	CcSEcCtD
Alendronate—ATP6V1A—Disease—FGA—osteoporosis	1.54e-05	0.00266	CbGpPWpGaD
Alendronate—Pruritus—Ibandronate—osteoporosis	1.54e-05	0.000539	CcSEcCtD
Alendronate—Constipation—Risedronate—osteoporosis	1.53e-05	0.000537	CcSEcCtD
Alendronate—Pain—Risedronate—osteoporosis	1.53e-05	0.000537	CcSEcCtD
Alendronate—Asthenia—Calcitriol—osteoporosis	1.53e-05	0.000536	CcSEcCtD
Alendronate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	1.51e-05	0.000531	CcSEcCtD
Alendronate—Pruritus—Calcitriol—osteoporosis	1.51e-05	0.000528	CcSEcCtD
Alendronate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	1.5e-05	0.000527	CcSEcCtD
Alendronate—Diarrhoea—Raloxifene—osteoporosis	1.5e-05	0.000527	CcSEcCtD
Alendronate—Dyspepsia—Pamidronate—osteoporosis	1.5e-05	0.000526	CcSEcCtD
Alendronate—Dizziness—Estropipate—osteoporosis	1.5e-05	0.000526	CcSEcCtD
Alendronate—Alopecia—Estradiol—osteoporosis	1.49e-05	0.000523	CcSEcCtD
Alendronate—Infection—Conjugated Estrogens—osteoporosis	1.49e-05	0.000522	CcSEcCtD
Alendronate—FDPS—Metabolism—IDH2—osteoporosis	1.49e-05	0.00257	CbGpPWpGaD
Alendronate—Diarrhoea—Ibandronate—osteoporosis	1.49e-05	0.000522	CcSEcCtD
Alendronate—Erythema—Estradiol—osteoporosis	1.47e-05	0.000515	CcSEcCtD
Alendronate—Gastrointestinal pain—Risedronate—osteoporosis	1.47e-05	0.000514	CcSEcCtD
Alendronate—Urticaria—Ethinyl Estradiol—osteoporosis	1.46e-05	0.000512	CcSEcCtD
Alendronate—Pain—Pamidronate—osteoporosis	1.46e-05	0.000511	CcSEcCtD
Alendronate—Constipation—Pamidronate—osteoporosis	1.46e-05	0.000511	CcSEcCtD
Alendronate—Diarrhoea—Calcitriol—osteoporosis	1.46e-05	0.000511	CcSEcCtD
Alendronate—Body temperature increased—Ethinyl Estradiol—osteoporosis	1.45e-05	0.00051	CcSEcCtD
Alendronate—Abdominal pain—Ethinyl Estradiol—osteoporosis	1.45e-05	0.00051	CcSEcCtD
Alendronate—Dizziness—Raloxifene—osteoporosis	1.45e-05	0.000509	CcSEcCtD
Alendronate—Flatulence—Estradiol—osteoporosis	1.45e-05	0.000508	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—TLN1—osteoporosis	1.44e-05	0.00249	CbGpPWpGaD
Alendronate—Vomiting—Estropipate—osteoporosis	1.44e-05	0.000506	CcSEcCtD
Alendronate—Dysgeusia—Estradiol—osteoporosis	1.44e-05	0.000505	CcSEcCtD
Alendronate—Dizziness—Ibandronate—osteoporosis	1.44e-05	0.000504	CcSEcCtD
Alendronate—Rash—Estropipate—osteoporosis	1.43e-05	0.000501	CcSEcCtD
Alendronate—Dermatitis—Estropipate—osteoporosis	1.43e-05	0.000501	CcSEcCtD
Alendronate—Urticaria—Risedronate—osteoporosis	1.42e-05	0.000499	CcSEcCtD
Alendronate—Headache—Estropipate—osteoporosis	1.42e-05	0.000498	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Zoledronate—osteoporosis	1.42e-05	0.000497	CcSEcCtD
Alendronate—Abdominal pain—Risedronate—osteoporosis	1.42e-05	0.000497	CcSEcCtD
Alendronate—Body temperature increased—Risedronate—osteoporosis	1.42e-05	0.000497	CcSEcCtD
Alendronate—Muscle spasms—Estradiol—osteoporosis	1.41e-05	0.000495	CcSEcCtD
Alendronate—Feeling abnormal—Pamidronate—osteoporosis	1.4e-05	0.000492	CcSEcCtD
Alendronate—FDPS—Metabolism—CYP27A1—osteoporosis	1.4e-05	0.00241	CbGpPWpGaD
Alendronate—Vomiting—Raloxifene—osteoporosis	1.4e-05	0.00049	CcSEcCtD
Alendronate—Gastrointestinal pain—Pamidronate—osteoporosis	1.39e-05	0.000489	CcSEcCtD
Alendronate—Rash—Raloxifene—osteoporosis	1.38e-05	0.000486	CcSEcCtD
Alendronate—Dermatitis—Raloxifene—osteoporosis	1.38e-05	0.000485	CcSEcCtD
Alendronate—Vomiting—Ibandronate—osteoporosis	1.38e-05	0.000485	CcSEcCtD
Alendronate—Headache—Raloxifene—osteoporosis	1.38e-05	0.000483	CcSEcCtD
Alendronate—ATP6V1A—Disease—ENO1—osteoporosis	1.37e-05	0.00237	CbGpPWpGaD
Alendronate—Rash—Ibandronate—osteoporosis	1.37e-05	0.000481	CcSEcCtD
Alendronate—Dermatitis—Ibandronate—osteoporosis	1.37e-05	0.00048	CcSEcCtD
Alendronate—Dyspepsia—Zoledronate—osteoporosis	1.37e-05	0.00048	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	1.36e-05	0.000479	CcSEcCtD
Alendronate—Ill-defined disorder—Estradiol—osteoporosis	1.36e-05	0.000478	CcSEcCtD
Alendronate—Headache—Ibandronate—osteoporosis	1.36e-05	0.000478	CcSEcCtD
Alendronate—FDPS—Metabolism—ACP5—osteoporosis	1.36e-05	0.00235	CbGpPWpGaD
Alendronate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	1.35e-05	0.000475	CcSEcCtD
Alendronate—ATP6V1A—Disease—PSMA5—osteoporosis	1.35e-05	0.00233	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PSMA2—osteoporosis	1.35e-05	0.00233	CbGpPWpGaD
Alendronate—Vomiting—Calcitriol—osteoporosis	1.35e-05	0.000475	CcSEcCtD
Alendronate—Nausea—Estropipate—osteoporosis	1.35e-05	0.000472	CcSEcCtD
Alendronate—Body temperature increased—Pamidronate—osteoporosis	1.35e-05	0.000472	CcSEcCtD
Alendronate—Abdominal pain—Pamidronate—osteoporosis	1.35e-05	0.000472	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.34e-05	0.00232	CbGpPWpGaD
Alendronate—Angioedema—Estradiol—osteoporosis	1.34e-05	0.000471	CcSEcCtD
Alendronate—Rash—Calcitriol—osteoporosis	1.34e-05	0.000471	CcSEcCtD
Alendronate—Dermatitis—Calcitriol—osteoporosis	1.34e-05	0.00047	CcSEcCtD
Alendronate—Headache—Calcitriol—osteoporosis	1.33e-05	0.000468	CcSEcCtD
Alendronate—Constipation—Zoledronate—osteoporosis	1.33e-05	0.000467	CcSEcCtD
Alendronate—Pain—Zoledronate—osteoporosis	1.33e-05	0.000467	CcSEcCtD
Alendronate—Malaise—Estradiol—osteoporosis	1.32e-05	0.000465	CcSEcCtD
Alendronate—Hypersensitivity—Risedronate—osteoporosis	1.32e-05	0.000463	CcSEcCtD
Alendronate—Vertigo—Estradiol—osteoporosis	1.32e-05	0.000463	CcSEcCtD
Alendronate—Dyspepsia—Conjugated Estrogens—osteoporosis	1.32e-05	0.000463	CcSEcCtD
Alendronate—Asthenia—Ethinyl Estradiol—osteoporosis	1.32e-05	0.000462	CcSEcCtD
Alendronate—Nausea—Raloxifene—osteoporosis	1.3e-05	0.000458	CcSEcCtD
Alendronate—Pruritus—Ethinyl Estradiol—osteoporosis	1.3e-05	0.000456	CcSEcCtD
Alendronate—Nausea—Ibandronate—osteoporosis	1.29e-05	0.000453	CcSEcCtD
Alendronate—Asthenia—Risedronate—osteoporosis	1.29e-05	0.000451	CcSEcCtD
Alendronate—Feeling abnormal—Zoledronate—osteoporosis	1.28e-05	0.00045	CcSEcCtD
Alendronate—Pain—Conjugated Estrogens—osteoporosis	1.28e-05	0.000449	CcSEcCtD
Alendronate—Constipation—Conjugated Estrogens—osteoporosis	1.28e-05	0.000449	CcSEcCtD
Alendronate—Gastrointestinal pain—Zoledronate—osteoporosis	1.27e-05	0.000446	CcSEcCtD
Alendronate—Pruritus—Risedronate—osteoporosis	1.27e-05	0.000445	CcSEcCtD
Alendronate—FDPS—Metabolism—TPI1—osteoporosis	1.27e-05	0.00218	CbGpPWpGaD
Alendronate—Nausea—Calcitriol—osteoporosis	1.26e-05	0.000443	CcSEcCtD
Alendronate—ATP6V1A—Disease—CALCA—osteoporosis	1.26e-05	0.00217	CbGpPWpGaD
Alendronate—Diarrhoea—Ethinyl Estradiol—osteoporosis	1.26e-05	0.000441	CcSEcCtD
Alendronate—Hypersensitivity—Pamidronate—osteoporosis	1.25e-05	0.00044	CcSEcCtD
Alendronate—Myalgia—Estradiol—osteoporosis	1.25e-05	0.000439	CcSEcCtD
Alendronate—Chest pain—Estradiol—osteoporosis	1.25e-05	0.000439	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—P4HB—osteoporosis	1.24e-05	0.00215	CbGpPWpGaD
Alendronate—Urticaria—Zoledronate—osteoporosis	1.24e-05	0.000433	CcSEcCtD
Alendronate—Discomfort—Estradiol—osteoporosis	1.24e-05	0.000433	CcSEcCtD
Alendronate—Abdominal pain—Zoledronate—osteoporosis	1.23e-05	0.000431	CcSEcCtD
Alendronate—Body temperature increased—Zoledronate—osteoporosis	1.23e-05	0.000431	CcSEcCtD
Alendronate—Diarrhoea—Risedronate—osteoporosis	1.23e-05	0.00043	CcSEcCtD
Alendronate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	1.23e-05	0.00043	CcSEcCtD
Alendronate—Asthenia—Pamidronate—osteoporosis	1.22e-05	0.000429	CcSEcCtD
Alendronate—Dizziness—Ethinyl Estradiol—osteoporosis	1.22e-05	0.000426	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PTH—osteoporosis	1.21e-05	0.00209	CbGpPWpGaD
Alendronate—Pruritus—Pamidronate—osteoporosis	1.21e-05	0.000423	CcSEcCtD
Alendronate—Infection—Estradiol—osteoporosis	1.19e-05	0.000418	CcSEcCtD
Alendronate—Urticaria—Conjugated Estrogens—osteoporosis	1.19e-05	0.000417	CcSEcCtD
Alendronate—FDPS—Metabolism—P4HB—osteoporosis	1.19e-05	0.00205	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RAP1A—osteoporosis	1.19e-05	0.00205	CbGpPWpGaD
Alendronate—Dizziness—Risedronate—osteoporosis	1.18e-05	0.000416	CcSEcCtD
Alendronate—Body temperature increased—Conjugated Estrogens—osteoporosis	1.18e-05	0.000415	CcSEcCtD
Alendronate—Abdominal pain—Conjugated Estrogens—osteoporosis	1.18e-05	0.000415	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CNR2—osteoporosis	1.18e-05	0.00203	CbGpPWpGaD
Alendronate—Vomiting—Ethinyl Estradiol—osteoporosis	1.17e-05	0.00041	CcSEcCtD
Alendronate—FDPS—Metabolism—GAPDH—osteoporosis	1.17e-05	0.00201	CbGpPWpGaD
Alendronate—Diarrhoea—Pamidronate—osteoporosis	1.17e-05	0.000409	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—NFATC1—osteoporosis	1.16e-05	0.002	CbGpPWpGaD
Alendronate—Rash—Ethinyl Estradiol—osteoporosis	1.16e-05	0.000406	CcSEcCtD
Alendronate—Dermatitis—Ethinyl Estradiol—osteoporosis	1.16e-05	0.000406	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—DKK1—osteoporosis	1.15e-05	0.00199	CbGpPWpGaD
Alendronate—Headache—Ethinyl Estradiol—osteoporosis	1.15e-05	0.000404	CcSEcCtD
Alendronate—Hypersensitivity—Zoledronate—osteoporosis	1.15e-05	0.000402	CcSEcCtD
Alendronate—ATP6V1A—Disease—KL—osteoporosis	1.15e-05	0.00197	CbGpPWpGaD
Alendronate—Vomiting—Risedronate—osteoporosis	1.14e-05	0.0004	CcSEcCtD
Alendronate—FDPS—Metabolism—RAP1A—osteoporosis	1.14e-05	0.00196	CbGpPWpGaD
Alendronate—Rash—Risedronate—osteoporosis	1.13e-05	0.000396	CcSEcCtD
Alendronate—Dermatitis—Risedronate—osteoporosis	1.13e-05	0.000396	CcSEcCtD
Alendronate—Dizziness—Pamidronate—osteoporosis	1.13e-05	0.000395	CcSEcCtD
Alendronate—Headache—Risedronate—osteoporosis	1.12e-05	0.000394	CcSEcCtD
Alendronate—Asthenia—Zoledronate—osteoporosis	1.12e-05	0.000392	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—WNT1—osteoporosis	1.11e-05	0.00191	CbGpPWpGaD
Alendronate—Hypersensitivity—Conjugated Estrogens—osteoporosis	1.1e-05	0.000387	CcSEcCtD
Alendronate—Pruritus—Zoledronate—osteoporosis	1.1e-05	0.000386	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Estradiol—osteoporosis	1.09e-05	0.000383	CcSEcCtD
Alendronate—Nausea—Ethinyl Estradiol—osteoporosis	1.09e-05	0.000383	CcSEcCtD
Alendronate—Vomiting—Pamidronate—osteoporosis	1.08e-05	0.00038	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FGA—osteoporosis	1.08e-05	0.00186	CbGpPWpGaD
Alendronate—Asthenia—Conjugated Estrogens—osteoporosis	1.07e-05	0.000377	CcSEcCtD
Alendronate—Rash—Pamidronate—osteoporosis	1.07e-05	0.000377	CcSEcCtD
Alendronate—Dermatitis—Pamidronate—osteoporosis	1.07e-05	0.000376	CcSEcCtD
Alendronate—Headache—Pamidronate—osteoporosis	1.07e-05	0.000374	CcSEcCtD
Alendronate—Diarrhoea—Zoledronate—osteoporosis	1.06e-05	0.000373	CcSEcCtD
Alendronate—Nausea—Risedronate—osteoporosis	1.06e-05	0.000373	CcSEcCtD
Alendronate—Pruritus—Conjugated Estrogens—osteoporosis	1.06e-05	0.000372	CcSEcCtD
Alendronate—Dyspepsia—Estradiol—osteoporosis	1.06e-05	0.00037	CcSEcCtD
Alendronate—Dizziness—Zoledronate—osteoporosis	1.03e-05	0.000361	CcSEcCtD
Alendronate—Pain—Estradiol—osteoporosis	1.03e-05	0.00036	CcSEcCtD
Alendronate—Constipation—Estradiol—osteoporosis	1.03e-05	0.00036	CcSEcCtD
Alendronate—Diarrhoea—Conjugated Estrogens—osteoporosis	1.03e-05	0.00036	CcSEcCtD
Alendronate—Nausea—Pamidronate—osteoporosis	1.01e-05	0.000355	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PTHLH—osteoporosis	1e-05	0.00173	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—BMP2—osteoporosis	1e-05	0.00173	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.92e-06	0.00171	CbGpPWpGaD
Alendronate—Dizziness—Conjugated Estrogens—osteoporosis	9.91e-06	0.000347	CcSEcCtD
Alendronate—Vomiting—Zoledronate—osteoporosis	9.89e-06	0.000347	CcSEcCtD
Alendronate—Feeling abnormal—Estradiol—osteoporosis	9.88e-06	0.000347	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FGB—osteoporosis	9.82e-06	0.00169	CbGpPWpGaD
Alendronate—Rash—Zoledronate—osteoporosis	9.81e-06	0.000344	CcSEcCtD
Alendronate—Gastrointestinal pain—Estradiol—osteoporosis	9.8e-06	0.000344	CcSEcCtD
Alendronate—Dermatitis—Zoledronate—osteoporosis	9.8e-06	0.000344	CcSEcCtD
Alendronate—Headache—Zoledronate—osteoporosis	9.75e-06	0.000342	CcSEcCtD
Alendronate—Vomiting—Conjugated Estrogens—osteoporosis	9.53e-06	0.000334	CcSEcCtD
Alendronate—Urticaria—Estradiol—osteoporosis	9.53e-06	0.000334	CcSEcCtD
Alendronate—Abdominal pain—Estradiol—osteoporosis	9.48e-06	0.000332	CcSEcCtD
Alendronate—Body temperature increased—Estradiol—osteoporosis	9.48e-06	0.000332	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PSMA5—osteoporosis	9.48e-06	0.00163	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PSMA2—osteoporosis	9.48e-06	0.00163	CbGpPWpGaD
Alendronate—Rash—Conjugated Estrogens—osteoporosis	9.45e-06	0.000331	CcSEcCtD
Alendronate—Dermatitis—Conjugated Estrogens—osteoporosis	9.44e-06	0.000331	CcSEcCtD
Alendronate—Headache—Conjugated Estrogens—osteoporosis	9.39e-06	0.000329	CcSEcCtD
Alendronate—Nausea—Zoledronate—osteoporosis	9.24e-06	0.000324	CcSEcCtD
Alendronate—FDPS—Metabolism—ENO1—osteoporosis	9.19e-06	0.00159	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PSMA2—osteoporosis	9.06e-06	0.00156	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PSMA5—osteoporosis	9.06e-06	0.00156	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ADCY5—osteoporosis	8.97e-06	0.00155	CbGpPWpGaD
Alendronate—Nausea—Conjugated Estrogens—osteoporosis	8.9e-06	0.000312	CcSEcCtD
Alendronate—Hypersensitivity—Estradiol—osteoporosis	8.83e-06	0.00031	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CALCA—osteoporosis	8.83e-06	0.00152	CbGpPWpGaD
Alendronate—Asthenia—Estradiol—osteoporosis	8.6e-06	0.000302	CcSEcCtD
Alendronate—Pruritus—Estradiol—osteoporosis	8.48e-06	0.000298	CcSEcCtD
Alendronate—ATP6V1A—Disease—MTHFR—osteoporosis	8.25e-06	0.00142	CbGpPWpGaD
Alendronate—Diarrhoea—Estradiol—osteoporosis	8.2e-06	0.000288	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—KL—osteoporosis	8.02e-06	0.00138	CbGpPWpGaD
Alendronate—Dizziness—Estradiol—osteoporosis	7.93e-06	0.000278	CcSEcCtD
Alendronate—ATP6V1A—Disease—IRS2—osteoporosis	7.85e-06	0.00135	CbGpPWpGaD
Alendronate—Vomiting—Estradiol—osteoporosis	7.62e-06	0.000267	CcSEcCtD
Alendronate—Rash—Estradiol—osteoporosis	7.56e-06	0.000265	CcSEcCtD
Alendronate—Dermatitis—Estradiol—osteoporosis	7.55e-06	0.000265	CcSEcCtD
Alendronate—Headache—Estradiol—osteoporosis	7.51e-06	0.000263	CcSEcCtD
Alendronate—FDPS—Metabolism—CYP19A1—osteoporosis	7.35e-06	0.00127	CbGpPWpGaD
Alendronate—Nausea—Estradiol—osteoporosis	7.12e-06	0.00025	CcSEcCtD
Alendronate—ATP6V1A—Disease—IRS1—osteoporosis	6.85e-06	0.00118	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6R—osteoporosis	6.44e-06	0.00111	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADCY5—osteoporosis	6.28e-06	0.00108	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SPP1—osteoporosis	6.08e-06	0.00105	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ADCY5—osteoporosis	6.01e-06	0.00104	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GPX1—osteoporosis	5.99e-06	0.00103	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MTHFR—osteoporosis	5.52e-06	0.000952	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IRS2—osteoporosis	5.5e-06	0.000948	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LEP—osteoporosis	5.38e-06	0.000927	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ESR1—osteoporosis	5.14e-06	0.000885	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IRS1—osteoporosis	4.8e-06	0.000827	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—POMC—osteoporosis	4.62e-06	0.000797	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6R—osteoporosis	4.51e-06	0.000777	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1—osteoporosis	4.44e-06	0.000766	CbGpPWpGaD
Alendronate—FDPS—Metabolism—POMC—osteoporosis	4.42e-06	0.000762	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MYC—osteoporosis	3.81e-06	0.000658	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFB1—osteoporosis	3.81e-06	0.000656	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—osteoporosis	2.87e-06	0.000494	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MYC—osteoporosis	2.67e-06	0.00046	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFB1—osteoporosis	2.66e-06	0.000459	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—osteoporosis	2.01e-06	0.000346	CbGpPWpGaD
